» Articles » PMID: 22927869

Aspirin Sensitivity and Chronic Rhinosinusitis with Polyps: a Fatal Combination

Overview
Date 2012 Aug 29
PMID 22927869
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aspirin-exacerbated respiratory disease (AERD) refers to aspirin sensitivity, chronic rhinosinusitis (CRS), nasal polyposis, asthma, eosinophil inflammation in the upper and lower airways, urticaria, angioedema, and anaphylaxis following the ingestion of NSAIDs. Epidemiologic and pathophysiological links between these diseases are established. The precise pathogenesis remains less defined, even though there is some progress in the understanding of several molecular mechanisms. Nevertheless, these combinations of diseases in patients classified by AERD constitute a fatal combination and may be difficult to treat with standard medical and surgical interventions. This paper reviews in brief the epidemiology, clinical features, diagnosis, molecular pathogenesis, and specific therapies of patients classified by AERD and postulates future attempts to gain new insights into this disease.

Citing Articles

Epidemiology, Sociodemographic Factors and Comorbidity for Allergic Rhinitis, Asthma, and Rhinosinusitis Among 15 to 65-year-Old Iranian Patients.

Nabavizadeh S, Moghtaderi M, Alyasin S, Esmaeilzadeh H, Teshnizi S, Jabbari-Azad F Med J Islam Repub Iran. 2023; 36:128.

PMID: 36620471 PMC: 9805810. DOI: 10.47176/mjiri.36.128.


Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.

Wong M, Keith P Allergy Asthma Clin Immunol. 2020; 16:72.

PMID: 32944029 PMC: 7491258. DOI: 10.1186/s13223-020-00461-x.


Kounis syndrome induced by oral intake of aspirin: case report and literature review.

El Hangouche A, Lamliki O, Oukerraj L, Dakka T, Doghmi N, Zarzur J Pan Afr Med J. 2019; 30:301.

PMID: 30637085 PMC: 6320451. DOI: 10.11604/pamj.2018.30.301.14948.


Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.

Philpott C, Sunkaraneni S, Wilson A, Erskine S, Philpott C, Clark A Respir Res. 2018; 19(1):129.

PMID: 29945606 PMC: 6020303. DOI: 10.1186/s12931-018-0823-y.


Aspirin-exacerbated respiratory disease and current treatment modalities.

Sakalar E, Bayar Muluk N, Kar M, Cingi C Eur Arch Otorhinolaryngol. 2016; 274(3):1291-1300.

PMID: 27538737 DOI: 10.1007/s00405-016-4273-1.


References
1.
Stewart R, Ram B, Hamilton G, Weiner J, Kane K . Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngol Head Neck Surg. 2008; 139(5):682-7. DOI: 10.1016/j.otohns.2008.07.010. View

2.
Guilemany J, Roca-Ferrer J, Mullol J . Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis. Curr Allergy Asthma Rep. 2008; 8(3):219-26. DOI: 10.1007/s11882-008-0037-3. View

3.
SETTIPANE G, CHAFEE F . Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol. 1977; 59(1):17-21. DOI: 10.1016/0091-6749(77)90171-3. View

4.
Picado C . Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep. 2002; 2(6):488-93. DOI: 10.1007/s11882-002-0089-8. View

5.
Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B . Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med. 2004; 10(1):51-6. DOI: 10.1097/00063198-200401000-00009. View